FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease | Landmark decision heralds a new type of medicine that can tackle genetic conditions that are hard to treat
The key thing about this kind of therapy is that it’s not a drug you keep on taking - it’s a one-time thing which permanently cures the disease.